Ligand Pharmaceuticals Inc Annual Shareholders Meeting Transcript
Good morning, and welcome to the Annual Meeting of Shareholders of Ligand Pharmaceuticals Incorporated. Please note that today's meeting is being recorded. (Operator Instructions)
It's now my pleasure to turn today's meeting over to Mr. Charles Berkman, Senior Vice President, General Counsel and Secretary of Ligand. Mr. Berkman, the floor is yours.
Welcome to Ligand's annual meeting. I am Charles Berkman, Ligand's General Counsel, and I will act as Chairman and Secretary for this meeting.
We are hosting this year's annual meeting in a virtual-only format. If you encounter any technical difficulties accessing or participating in the meeting, please refer to the support link on the virtual meeting website for information on how to reach your support team.
Computershare, represented by Mark Cano, will act as the inspector of elections. Also attending today's meeting is Emma Epes from Ernst & Young LLP, the company's independent
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |